Related Experiment Video
Updated: May 30, 2025
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Exploring hypertension-linked diseases: a comprehensive review of innovative drug combinations with enhanced
Bhavesh Thakkar1, Hetvi Dadhaniya1, Kiran Dudhat2
1School of Pharmacy, RK University, Kasturbadham, Rajkot, Gujarat, 360020, India.
Insights
Hypertension management is evolving beyond traditional methods. New pharmaceutical agents, devices, and non-invasive techniques show promise in improving blood pressure control and reducing complications for patients.
Area of Science:
- Cardiovascular Medicine
- Medical Technology
- Pharmacology
Background:
- Hypertension is a widespread cardiovascular disease with serious complications.
- Current treatments like lifestyle changes, diet, and medication often fail to achieve optimal blood pressure control.
- There is a significant unmet need for more effective hypertension management strategies.
Purpose of the Study:
- To comprehensively review hypertension, its complications, and emerging novel management techniques.
- To critically analyze the efficacy and safety of new therapeutic approaches in preclinical and clinical studies.
- To explore the potential impact of innovative strategies on patient outcomes and the overall therapeutic landscape.
Main Methods:
- Review of existing literature on hypertension and its management.
- Analysis of preclinical and clinical study findings on novel hypertension interventions.
- Critical discussion of pharmaceutical agents, medical devices, and non-invasive techniques for hypertension.
Main Results:
- Emerging management techniques, including new pharmaceutical agents, medical devices, and non-invasive interventions, show promise.
- These novel approaches demonstrate potential efficacy and safety in preclinical and clinical settings.
- The findings suggest a transformative potential for these new strategies in managing hypertension.
Conclusions:
- Innovative management techniques offer a promising new avenue for addressing the challenges of hypertension.
- These advancements have the potential to significantly improve patient care and quality of life.
- Further research and application of novel strategies may lead to reduced hypertension-related morbidity and mortality.
Abstract:
Hypertension, a prevalent cardiovascular condition affecting a substantial portion of the global population, remains a formidable health challenge associated with a multitude of complications. This review article provides a comprehensive examination of hypertension, its various complications, and the emergence of a novel management technique that shows promising potential in transforming the therapeutic landscape. Over the years, conventional treatment approaches, encompassing lifestyle modifications, dietary interventions, and pharmacotherapy, have been the mainstay in managing hypertension. However, these strategies fall short in achieving optimal blood pressure control and preventing complications in a significant number of patients. Consequently, the medical community has ventured into exploring innovative management techniques to tackle this unmet medical need. The focal point of this review centers on the emergence of a new management technique for hypertension that exhibits promise in preclinical and clinical studies. The latest research findings shed light on the efficacy and safety of this innovative approach, which encompasses pharmaceutical agents, medical devices, and non-invasive interventions. Through critical analysis and discussion, we explore the potential impact of these novel strategies on hypertension management and patient outcomes. In conclusion, this review article provides a comprehensive overview of hypertension, its complications, and the promising emergence of innovative management techniques. By acknowledging the complexity of hypertension and the potential of new therapeutic avenues, we aspire to pave the way for improved patient care, enhanced quality of life, and ultimately, the mitigation of hypertension-related morbidity and mortality.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:33Hormonal Regulation
01:25Antihypertensive Drugs: Direct Renin Inhibitors
01:27Combined Effects of Drugs: Synergism
Such synergistic combinations...
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
01:22Heart Failure Drugs: Diuretics